Prolylcarboxypeptidase promotes IGF1R/HER3 signaling and is a potential target to improve endocrine therapy response in estrogen receptor positive breast cancer

Prolylcarboxypeptidase (PRCP) is a lysosomal serine protease that cleaves peptide substrates when the penultimate amino acid is proline. Previous studies have linked PRCP to blood-pressure and appetite control through its ability to cleave peptide substrates such as angiotensin II and α-MSH. A poten...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Lei, Calhoun, Sarah J., Perez, Ricardo E., Macias, Virgilia, Mir, Fatima, Gattuso, Paolo, Maki, Carl G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639567/
https://www.ncbi.nlm.nih.gov/pubmed/36332175
http://dx.doi.org/10.1080/15384047.2022.2142008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639567/
https://www.ncbi.nlm.nih.gov/pubmed/36332175
http://dx.doi.org/10.1080/15384047.2022.2142008

Ejemplares similares